Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Katarzyna Mołoniewicz"'
Publikováno v:
Pharmacological Reports
Background Human recombinant erythropoietin (rHuEPO) is often used in the treatment of diseases associated with a decreased production of red blood cells (RBC), such as chronic renal failure. rHuEPO is typically administered as an intravenous or subc